Key result
Sildenafil attenuated ethanol-induced cardiomyocyte apoptosis and necrosis, preserved mitochondrial integrity, and maintained cardiac function in mice via protein kinase G-dependent signaling.
Why the study?
Does sildenafil prevent ethanol-induced cardiotoxicity and preserve cardiac function in preclinical models?
Does sildenafil prevent ethanol-induced cardiotoxicity and preserve cardiac function in preclinical models?
Sildenafil protects against acute ethanol-induced cardiotoxicity and preserves cardiac function via PKG-dependent signaling in preclinical models.
Sildenafil may attenuate ethanol cardiotoxicity in animals; leaves open translation to human alcoholic cardiomyopathy.
Background: Ethanol is a cardiotoxic substance that damages the heart by increasing apoptosis, free radical formation and calcium overloading. Consequently, there is an increase in cell death leaving fewer functioning myocytes leading to heart failure. Sildenafil is a phosphodiesterase type-5 (PDE-5) inhibitor approved for treatment of erectile dysfunction. Studies from our lab have demonstrated that PDE-5 inhibition reduces myocardial infarct size and attenuates post-ischemic cardiac dysfunction in both ischemia-reperfusion and permanent coronary artery ligation models. Therefore, in the present study, we hypothesized that treatment with sildenafil will prevent cardiotoxicity associated with acute alcohol exposure by reducing myocyte apoptosis and preserving cardiac function through PKG signaling. Methods and Results: Adult cardiomyocytes were isolated and treated with 100 mM of 100% ethanol ± 10 µM sildenafil. At 24 hours necrosis was assessed via trypan blue exclusion assay, JC-1 staining assessed mitochondrial membrane potential and ROS production was measured by DCF fluorescence. At 48 hours apoptosis was assessed by TUNEL assay. Ethanol increased the rate of necrotic and apoptotic cell death. This was attenuated by co-treatment with sildenafil. Ethanol disrupted the mitochondrial membrane potential and increased ROS production. Sildenafil preserved mitochondrial membrane potential and attenuated ROS production. Treatment of myocytes with 5-HD, a mitochondrial K+atp channel antagonist, blocked the protective effect of sildenafil. Knockdown of PKG using adenoviral siRNA blocked the protective effect of sildenafil, while overexpression of PKG1α conferred protection against ethanol cytotoxicity. To further demonstrate the effect of sildenafil ethanol-cardiotoxicity in vivo, mice were treated with ethanol (3 g/kg/day) with or without sildenafil (0.7 mg/kg) by i.p. injection for three consecutive days. After treatment, the animals were sacrificed and the hearts removed and perfused on a Langendorff system to measure function. After functional analysis, apoptosis and PKG activity was measured in the heart samples. Ethanol decreased the rate-force product and increased myocardial apoptosis. Sildenafil preserved cardiac function and significantly reduced apoptosis. Sildenafil treated myocardium also showed an increase in PKG activity. Conclusion: Sildenafil attenuates the toxic effect of ethanol by reducing apoptosis and maintaining the mitochondrial integrity in cardiomyocytes. Sildenafil also preserved cardiac function in ethanol-treated mice. Protein kinase G-dependent signaling plays a critical role in attenuating cardiotoxic effect of ethanol.
No takes yet. Share an insight, caveat, or question.
Gregory R. Sturz (2013) studied Ethanol-induced cardiotoxicity. Sildenafil vs. Ethanol alone was evaluated on Apoptosis, necrosis, mitochondrial membrane potential, ROS production, and cardiac function. Sildenafil attenuated ethanol-induced cardiomyocyte apoptosis and necrosis, preserved mitochondrial integrity, and maintained cardiac function in mice via protein kinase G-dependent signaling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: